Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7015 studies found for:    vaccine
Show Display Options
RSS Create an RSS feed from your search for:
vaccine
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
Condition: Prophylaxis of Avian Influenza Vaccine
Intervention: Biological: Fluad H5N1 Pandemic Influenza Vaccine
2 Completed Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009
Condition: Seasonal Influenza, Vaccine
Intervention: Biological: Seasonal Influenza Vaccine
3 Completed Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Condition: Plague Vaccine
Interventions: Biological: rF1V vaccine (with Adjuvant);   Biological: rF1V vaccine (without Adjuvant)
4 Unknown  Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection
Condition: Vaccine Overdose of Undetermined Intent
Interventions: Biological: prophylactic peptide vaccine;   Biological: therapeutic peptide vaccine
5 Completed Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects
Condition: Prepandemic Influenza Vaccine
Intervention: Biological: Monovalent inactivated influenza vaccine
6 Recruiting Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation
Condition: Staphylococcal Vaccine
Interventions: Biological: Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine;   Other: Placebo
7 Completed
Has Results
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
Conditions: Seasonal Influenza;   Vaccine
Interventions: Biological: Cell-derived influenza vaccine;   Biological: Egg-derived influenza vaccine
8 Completed Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Condition: Botulism Vaccine
Interventions: Biological: Placebo (USP sterile saline for injection);   Biological: rBV A/B-40 vaccine
9 Completed Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects
Condition: Seasonal Influenza
Intervention: Biological: Trivalent subunit inactivated flu vaccine, Formulation 2010-2011
10 Completed Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
Condition: Influenza Disease
Intervention: Biological: Influenza vaccine
11 Completed School Located Adolescent Vaccination Study
Condition: School Located Vaccine Program
Intervention: Behavioral: School Located Vaccine (SLV) Program
12 Completed
Has Results
Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
Condition: Seasonal Influenza Vaccine
Intervention: Biological: cTIV
13 Active, not recruiting Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Vaccine Response Impaired
Intervention: Biological: hepatitis A vaccine
14 Completed Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for DEN1;   Other: Placebo injection
15 Completed Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008
Condition: Influenza
Intervention: Biological: Surface antigen inactivated influenza vaccine
16 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
17 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
18 Completed Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008
Conditions: Seasonal Influenza;   Vaccine
Intervention: Biological: trivalent split influenza vaccine
19 Completed Auto-immunity in Lupus Patients After Influenza Vaccine
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Vaccine
20 Completed Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules
Condition: Pre-pandemic Influenza Vaccine
Intervention: Biological: Monovalent inactivated influenza vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.